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Introduction 
 
“Two component preparation of fibrin glue and its clinical evaluation in split skin grafting” 
Abstract: 
Management of a disrupted tissue is the core of  the research in this era and  conventional 
suturing and stapling is painful, time consuming  and expensive, tissue adhesives has erupted as 
a light to this dark. Fibrin glue used in this study is a biological tissue adhesive and is chosen to 
check for its anchorage, graft uptake, soakage and infection rate. Its two components are 
fibrinogen and thrombin. Fibrinogen is obtained from cryoprecipitate and thrombin from 
screened donor’s fresh frozen plasma and the same is applied to 30 patients in the study 
undergoing split skin grafting. The results were compared to conventional suturing and staples. 
The fibrin glue tested in the study is a simple, efficacious, cost-effective, less time consuming, 
better graft uptake, less seroma formation, minimum infection, easy and comfortable intra-
operative and post-operative care and patients can be made ambulant early. 
Key words: Sutures, staples, fibrin glue, fibrinogen, thrombin, cryoprecipitate, fresh frozen 
plasma, graft uptake, seroma, infection. 
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                                       INTRODUCTION 
     “We expose it, cover it, paint it, tattoo it, scar it, and pierce it. Our intimate 
connection with the world, skin protects us while advertising our health, our 
identity and our individuality”. 
                  Skin is the outer covering of vertebrates and the largest organ of our  
 integumentary system which is ectodermal in origin and is made up of multiple 
 layers and thereby covers and guards the underlying structures such as muscles, 
 ligaments, bones and internal organs. The most important of all is that, skin is an 
 indispensible barrier which protects us all through the life, from  birth to death 
against physical, chemical and mechanical stress.  
     Though skin ages as life fades off, but it proves no threat to a person 
 except for the insult on the psychology of a person and this change is inevitable.  
With the changing population and lifestyle and the intrusion of many diseases in  
developing countries like India, besides the skin being the most superficial part and  
having the multi-tasking capacity, it is exposed to a lot of  infections, diseases and 
injuries. 
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           With the exploding population and road traffic accidents, traumatic injury  
to the skin has also become very much common. With raising epidemic and India  
becoming the diabetic capital of the world, diabetic ulcer has been a common and  
challenging problem to avoid and to treat. 
            Skin grafting came as a major breakthrough in treating ulcers and raw areas 
which cannot be closed primarily and is still evolving. Way back in 1804, Baronio 
performed the first skin grafting on a lamb. This led to the evolution of skin 
grafting where the first auto transplantation of the skin was done by placing a  
2-3mm epidermal graft on a granulating wound, which was done by Jacques 
Reverdin, a Swedish medical student in Paris in 1869.  
           His experiment not only demonstrated that the skin transferred from one 
part of an individual to other part of the same individual can survive but also 
showed that it can hasten wound healing.  
            Goerge Lawson was the first person to perform a full thickness graft 
successfully in 1871 followed by a French surgeon, Louis Ollier, who performed 
intermediate thickness graft as large as 8 cm
2
 in 1872.
 
  
        Carl Thiersch, a German surgeon in 1874 was first one to recognize the 
importance of preparing the recipient bed by removing the granulation tissue over 
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the wound before grafting, which dramatically improved the graft take and he 
erroneously thought taking thin grafts was required for better and faster healing of 
the donor site.  
       Even after experimenting on skin grafts over a century, many surgeons were 
not happy to go about the procedure because of the unreliability, difficulties faced 
while harvesting the grafts and some even suggested that it results in two wounds 
instead of one, until Otto Lanz described the method of meshing the grafts that 
increased the length of the graft which can be used for the recipient and the donor 
area.  
           In 1929, Vilray Papin Blair and James Barrett Brown, from Saint Louis 
differentiated split thickness, intermediate and full thickness grafts with reliable 
results with the advantages and disadvantages of each. They proposed a theory 
which holds true till today about the wound preparation, graft harvest, graft 
application, contraindications and post operative care. 
          This was followed by the Era of development of instruments for harvesting 
the grafts. In 1936, the first device was specifically built for harvesting a graft, the 
Humby’s knife that contained a razor with a guard which prevented the surgeon 
from cutting the harvest deeper. For the faster and precise harvests, dermatome 
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was developed, but the first power driven dermatome developed by James Barrett 
Brown, in 1945 is the most popular till date.  
         Once the graft is harvested, it can be fixed to the recipient bed using good old 
conventional method of sutures and staples. Due to the difficulties, disadvantages 
and skills mandated by the conventional method of suturing and stapling the graft, 
the idea of developing the tissue adhesive was then floated. 
        In 1909, BERGEL first reported use of fibrin as the biological adhesive, but 
TIDRICK and WARNER in 1944 used fibrin glue for fixing skin grafts. 
        Fibrin glue is an alternative to conventional suturing and stapling of skin 
grafts and has some added advantages. Conventional methods had some demerits 
like foreign body reaction, scarring, infection, pain during removal and was 
expensive too, whereas the use of fibrin glue is simple, safe and cost-effective 
method, with a rapid technique to fix the skin graft, avoid per-operative bleeding 
and post-operative collection, better uptake of graft and better overall results.  
        This biological Fibrin glue initiates the final coagulation cascade, when 
human fibrinogen is activated by thrombin. Fibrin glue is a sealant and a 
hemostatic agent with an added adhesive property that has been reportedly used in 
many specialties with better outcomes. 
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       Many techniques have been developed to produce fibrin which is 
commercially available and these have their own risks, expensive, cumbersome 
and time consuming. 
       In this study, fibrin glue which we have advocated  includes Cryoprecipitate, 
which is a rich source of fibrinogen and thrombin from screened healthy donor’s 
fresh frozen plasma, is less time consuming, cost-effective and safe and the same 
has been used in thirty patients admitted in Coimbatore medical college and 
hospital, Coimbatore. This study compares the effectiveness of fibrin glue with 
conventional sutures and staples. 
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                                       AIM OF THE STUDY 
OBJECTIVES: 
         “To study the effectiveness of fibrin glue in anchoring the split skin graft to 
the wound bed and to analyze the advantages, disadvantages and outcome of using 
fibrin glue compared to suturing and stapling”. 
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                             REVIEW OF LITERATURE 
             It is the largest human organ with a complex and fascinating structure and 
physiology and it is continuous with the epithelium of the respiratory, digestive 
and uro-genital tract. 
             The skin protects us by acting as a barrier against a vast number of 
destructive forces like chemical absorption (as epidermis acts as a semi permeable 
membrane), fluid loss, solar radiation and infectious agents and its dermal 
durability resists physical forces as well. 
            It plays an important role in sensation and internal metabolism. It acts as 
body’s primary thermoregulatory organ by regulating the body’s heat, which 
makes skin as a fascinating and one of the best studied tissues of the human body 
for analysis. 
SKIN ANATOMY AND PHYSIOLOGY: 
             Skin is the largest organ of the body. It is continuous with the epithelium 
of the respiratory, digestive and uro-genital tract. It plays an important role in the 
sensation and vitamin D metabolism. 
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               Skin consists of two layers, an avascular epidermis and a vascular dermis. 
The main function of epidermis is to build a tough layer of dead cells by a process 
called as Cornification, so that it can withstand the insult of the environment. 
Dermis is a vascular bed to the epidermis and has capillaries which regulate the 
temperature. 
  Epidermis: 
             It is the superficial layer and its thickness varies from 0.04 mm on the 
eyelid to 1.6mm over the palm. It contains distinct cells such as keratinocytes, 
melanocytes, Langerhans cells and Merkel cells. 
Embryology: 
               It first appears at the 3
rd
 week of gestation, as a single layer and it is a 
derivative of ectoderm. It then splits into basal germinal layer and outer glycogen 
rich flatter layer called Periderm, by 4
th
 week of gestation. The skin is cornified 
completely by 6
th
 month of gestation and a five layered distinct epidermis comes 
into existence.  
            The five layers are: Stratum Germinativum or basal layer, Stratum 
Spinosum or prickle cell layer, Stratum Granulosum, Stratum Lucidum and 
Stratum Corneum. Only the palms and soles have all the five layers and the rest of 
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the body contains only two layers, the stratum corneum and stratum germinativum 
respectively. 
          The melanocytes appear by 8
th
 week of gestation and are derived from the 
neural crest cells. Melanocytes transfer melanosomes (melanin) to the 
keratinocytes by the 5
th
 month of gestation. 
              The Langerhans cells are derived from haematopoetic cells and Merkel 
cells are thought to be derived from neural crest or from the ectoderm. 
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Functions: 
           The primary function of the skin is to act as a barrier and give the protection 
against the environment and organisms. A layer of dead cells covers the organism 
by the cornification process and acts as a barrier. Basal layer contains columnar or 
cuboidal cells, where the cornification begins. And these cells have large oval 
nuclei and basophilic cytoplasm.    
            Tono filaments are synthesized in the basal cells. Then they get aggregated 
and ascend through the epidermis and form a keratinous protein which gets 
accumulated in the cell to form a mature keratinocyte or corneocyte.             
            In stratum spinosum, the cells are polygonal in shape and resemble spines 
in light microscopy due to the cell to cell connections called Desmosomes.  
           Keratinohyalin granules are produced by keratinocytes in the stratum 
granulosum and these granules contain histidine rich cationic protein called 
Profilaggrin, which gets degraded to Filaggrin. This Filaggrin acts like a glue that 
holds the keratinofilaments together. Second type of granules called lamellar 
granules contains free sterols, polar lipids and several hydrolytic enzymes. These 
granules are thought to give the skin its impermeable quality, by establishing a 
hydrophilic crystalline sheet within the intercellular space in the cornified layer. 
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           Marginal band or the cornified cellular envelope is a thickening that 
develops along the top of the keratinocytic plasma membrane, which is formed by 
the disulphide and the other chemical bonds between keratolinin and involucrin. 
The multiple neutral lipids provide a strong integrity to the epidermis to withstand 
the chemical and physical insults of the environment. 
           Basal layer of the epidermis consists of melanocytes in the ratio of one 
melanocyte to every ten keratinocytes. The main function of the melanocytes is to 
produce melanosomes, which are vesicles full of melanin. 
 Melanin is of two types: Pheomelanin, which has characterstic lighter colour ,like 
blond or reddish and Eumelanin ,which accounts for black or brown colour. The 
prime function of melanin is to protect skin from the harmful effects of UV rays. 
Studies also support that melanin acts as a biochemical neutralizer of oxygen free 
radicals. 
        The middle layer of epidermis contains specialized cells called Langerhans 
cells. These Langerhans cells play an important role in immune mechanism by 
playing a large part in contact dermatitis, allograft rejection and neoplasia 
surveillance. 
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            Epidermis also consists of specialized cells called Merkel cells which are 
neurosensory cells. These Merkel cells are found in the epidermis of palms and 
soles, nail bed, oral and genital epithelium. Merkel cells are found close to the 
neurites and they act as melanoreceptors and transmit mechanical forces, to 
generate action potential along the nerve fibers. 
 
Dermis: 
             It is mainly composed of collagen, elastin fibres and ground matrix. When 
compared to epidermis, it is relatively non-cellular and consists of nerve, vessels, 
lymphocytes and glandular elements of the skin. Dermis is 15-40 times thicker 
than the epidermis but because of its lesser cellularity, it consumes lesser energy 
than epidermis. 
             The free cells found in the dermis are fibrocytes, mast cells, histiocytes, 
Langerhans cells, lymphocytes and rarely eosinophils. Dermis contains two layers 
namely, a superficial papillary dermis and a deep reticular layer.  
              The papillary dermis contains disorganized collagen bundles, elastic 
fibres, fibrocytes, ground substances and richly developed microcirculation. 
Epidermis does not have inherent blood supply and it gets blood supply from the 
microcirculation of dermis, for its metabolic activity. 
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        Reticular dermis consists of thick bundles of collagen fibres which are 
arranged in orthogonal fashion, interspersed by coarse elastic fibres.  
Periadenexal dermis: it is the dermis which is present immediately adjacent to the 
hair follicles, apocrine glands and eccrine glands. It resembles papillary dermis.  
         Ground substance is primarily composed of mucopolysaccharides, hyaluronic 
acid and chondroitin sulfate and these are mainly found in the papillary dermis and 
to a lesser extent in the reticular dermis. This provides the gel like consistency and 
with aging it is replaced by fibrous tissue. 
Dermal – epidermal junction: 
       It is the specialised site of attachment between the epidermis and the papillary 
dermis. It mainly contains basal keratinocytes, melanocytes and Merkel cells. 
         It has four layers when seen under the electron microscopy. First layer is 
made of hemidesmosomes, second layer- lamina lucida , third layer -lamina densa 
predominantly made up of type IV collagen and lastly a fibrous zone composed of 
anchoring fibrils, type III collagen and dermal microfibril bundles. 
Extra cellular matrix: Extra cellular matrix fulfils many biological functions such 
as tissue organization, growth factor reservoir, semi permeable selective barrier 
23 
 
and supporting cell monolayer during the tissue development. It contains anionic 
proteoglycan such as heparin sulfate which acts as a chemical barrier. 
        Dermis has dense extra cellular matrix(ECM) that supports the complex 
network of nerves, vasculature and adenexal structures. Apart from the 
architectural framework that imparts mechanical support and visco-elasticity , they 
regulate neighbouring cells along with their ability to migrate, proliferate and 
survive injury. 
Blood supply: 
       Skin gets its blood supply from the subdermal plexus. Subdermal plexus 
supplies the skin appendages and ends in the plexus present in the superficial 
layers of papillary dermis, from where capillary loops arise and supply the 
epidermis. Blood supply to the subdermal arterial plexus comes from two types of 
cutaneous perforators, the musculocutaneous perforators arising from the muscle 
and the direct cutaneous arteries from the segmental perforators. 
Venous drainage follows the arterial network. 
Graft is devoid of its blood supply, sensory innervations and drainage. So the graft 
entirely depends upon the recipient bed for survival. 
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SKIN GRAFT: 
Definition: 
 Grafting is the transfer of tissue from one area to another without its blood supply 
or nerve supply. 
Autograft:  
Autograft is the transfer of tissue from one location to another location in the same 
patient. 
Isograft : 
The transfer of the tissue between individuals who are genetically identical e.g. 
transfer between two identical twins. 
Xenograft (Heterograft): 
The transfer of the tissue between a donor of one species to a recipient of another 
species. 
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Skin grafting is the simplest method of wound closure in the reconstruction ladder 
when wound closure is not possible primarily or closure under tension. 
Full thickness grafts are usually applied over small areas and over the face, ears 
and hands, whereas split thickness graft is preferred over large areas and the trunk 
and genitalia. 
Indications for skin grafting: 
1. Any traumatic wound that cannot be closed primarily 
2. Defects after oncologic resection 
3. Burn reconstruction 
4. Scar contracture release 
5. Congenital deficiencies of skin, such as syndactaly and vaginal atresia 
6. Hair restoration 
7. Vitiligo 
8. Nipple areolar reconstruction 
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CONTRAINDICATIONS: 
Absolute: 
a.Wounds with avascular beds 
b. Infected wounds 
c. Wounds due to malignant neoplasia 
Relative:  
a. Pressure sores 
b. Wounds due to irradiation 
c. Wounds due to vasculitis 
d. Wounds due to arterial insufficiency 
e. Wounds in cosmetically sensitive areas 
f. Malnutrition  
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Classifications: 
Types 
A) Partial thickness graft (Split thickness graft or Thiersch graft) 
B) Full thickness graft (Wolf graft) 
Partial thickness graft: 
Partial thickness graft is the removal of whole of epidermis with a portion of 
dermis from the donor area. 
Depending on the dermis thickness it may be 
a) Thin SSG 
b) Intermediate SSG 
c) Thick SSG  
Donor sites: 
Split thickness graft can be taken from any part of the body, including the scalp 
region. Since the donor area becomes hyperpigmented or scarred frequently, it is 
chosen from the hidden areas of the body like thighs, trunk and buttocks. Facial 
defects are usually covered by full thickness grafts or local flaps. Rarely split skin 
graft is used which is chosen from the “BLUSH ZONE”. Blush zone includes the 
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area above the shoulder such as supraclavicular region, neck and scalp. Hair 
bearing region is usually avoided for the simple reason that if too thicker graft is 
taken, it may grow hairs once it is taken up well. 
       Men have thicker skin than the women irrespective of the site, whereas infants 
and elderly individuals have thinner skin. Skin over the trunk and thighs are thicker 
whereas eyelids and post auricular region have thinner skin. 
Donor site care: 
       Healing of the donor site after harvesting the split skin graft takes about 7-21 
days. Usually fine meshed gauze impregnated with lubricants and antibiotics is 
applied to the donor area after the split skin graft is taken and it is left on the donor 
site until it falls off. 
      This lubricated gauze gives protection as well as pain. Bilaminated membrane 
like BIOBRANE or water permeable, bio-occlusive plastic adhesives like OPSITE 
can also be used. 
      Ideal and optimum treatment of the harvest site is by auto grafting, so 
whenever possible excess skin should be auto grafted rather than discarding it. 
Cultured keratinocytes sheets, skin allografts and other skin substitutes have been 
developed to hasten faster healing of the donor site. 
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Harvesting: 
       Harvesting a graft can be done using either freehand or a power driven 
dermatome.WECK blade, HUMBY’s knife, BLAIR knife and simple scalpel are 
few examples of freehand dermatomes. Advantage of the freehand is that, it can be 
done quickly without the help of electric or pneumatic power, but one has to be 
careful in maintaining the exact thickness and depth of the graft.   
       Harvesting can be done under local anesthesia or regional nerve block. Once 
the site is chosen, WECK or BLAIR blade is mounted onto HUMBY’s knife. 
Typically the guard is set at 0.3-0.45mm to get the ideal thickness of split skin 
graft. 
     Once the instrument is ready, lubricant is applied to the area from where the 
graft needs to be harvested and the assistant applies tension. The surgeon then 
passes the knife parallel to the epidermis like a violin, in back and forth direction. 
Once harvested it is meshed and applied to the recipient area.  
     First electrically driven dermatome was developed by JAMES BARRETT 
BROWN in 1940. It uses rapidly vibrating blade which moves like a wood planar. 
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      Most commonly used motorized dermatome, AIR ZIMMER dermatome which 
is powered by compressed water pumped nitrogen, produces uniform grafts of 
predetermined depth and width.  
      Power source should be checked before using the power dermatome, until and 
unless it is battery driven. Usually the skin is harvested under general anesthesia 
when power dermatome is used, but can be done under local or regional block. 
Graft is harvested in the same way as the freehand dermatome with few 
modifications. 
Full thickness graft: 
       Generally scalpel is enough to harvest a full thickness graft. Usually it is 
preferred for small areas like face. Template is prepared and placed over the site 
from where the graft has to be harvested. A graft is harvested with the full 
thickness of the dermis with little or no subcutaneous fat. Donor site can be 
covered primarily or by split skin graft. 
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Advantages: 
SPLIT SKIN GRAFT FULL THICKNESS GRAFT 
Technically easier to perform Less contractures 
Wide area can be covered Color match is good 
Donor area heals by itself Sensation, hair follicles, functions of 
sebaceous glands are retained 
Graft take is better Cosmetically and functionally better 
 
Disadvantages: 
SPLIT THICKNESS GRAFT FULL THICKNESS GRAFT 
More contractures Can be used only over small areas 
More seroma and hematoma 
formation 
 Donor area needs to be covered 
Infection rate is more Cannot be used to cover ulcers 
Loss of hair growth, blunting of 
sensation 
 
Dry and scaly skin due to loss of 
sebaceous glands 
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GRAFT SURVIVAL: 
The process by which the graft survives are: 
a) Plasmatic imbibitions. 
b) Graft revascularization or inosculation. 
c) Maturation or neovascularisation. 
 
Plasmatic imbibtion: 
        Aubscher and Goldman were the first physicians, who identified the graft 
survives by serum nourishment and it was called plasmatic circulation. 
       Once the graft is placed on the recipient bed it becomes edematous and gains 
weight. Plasma which is leaked mainly from the venules and partly from the 
arterioles and capillaries get accumulated between the graft and the recipient. This 
plasma contains fibrinogen, which anchors the graft to the bed and provides 
nourishment. 
       Once the graft is placed on the recipient bed, it evacuates its blood and serum. 
The graft passively absorbs serum from the recipient bed, through the cut ends of 
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the vessels and porous dermis. Anaerobic metabolism takes place in the graft and 
this may stimulate revascularization. Endothelial in growth occurs throughout 
serum imbibition process and vascular flow occurs as quickly as possible. Thus 
both serum imbibiton and revascularization occurs together but separately. 
Graft revascularization: 
      Thiersch confirmed the process of inosculation in 1874 in histologic sections of 
full thickness graft. According to this theory, internal vessels of the recipient and 
the host bed line up and form an anastomosis which provides inflow and outflow to 
the graft (vascular connections have been shown to begin as early as 22hrs). 
     Another study done by Garre , Hubscher, Goldman , Iungengal and Endrlen 
demonstrated that the original vascularisation of the graft degenerates and 
endothelial cells and capillary buds from the host bed restores the blood flow by 
direct invasion. 
    Third theory proposed by Henry, suggested that the graft’s vasculature 
undergoes degeneration but the cellular basal lamina persists and this acts as 
conduit for the invasion of new blood vessels from the host bed. This was 
histologically proven by Henry, where he demonstrated patent vascular channels 
after 48 hrs in the skin grafts, which got endothelialised later by the host capillary 
bed invasion. 
34 
 
       Revascularization in the split skin graft can survive for a longer period without 
revascularization due to the fewer cellular components that are present in the split 
skin graft than full thickness graft. More so, the thick dermis acts as a barrier and 
hampers the process of diffusion during the serum imbibition. 
Graft maturation: 
      Graft continues to mature and contract after it is completely vascularised over 
6-12 months. Wound and graft contraction is the most significant event to occur 
during the maturation of the graft. The area which is not grafted will undergo 
natural healing by contraction mediated by myofibroblast, which occurs actively. 
Within the wound many fibroblasts differentiate into myofibroblasts and contract 
the wound, before the wound is grafted. The graft once planted will also contract 
depending upon the dimensions of the wound. This process is called Secondary 
contraction. The contraction in the graft which occurs after harvesting, is because 
of the inherent elastic property and this is called as Primary contraction. This 
primary contraction is more in the full thickness graft than split thickness graft. 
This can be easily overcome by stretching the graft before its application. 
Secondary contraction is well understood than the primary contraction. In 
secondary contraction dermis inhibits the myofibroblast differentiation, so full 
thickness graft goes for lesser secondary contraction than the split thickness graft.      
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This is the reason whenever possible full thickness graft should be applied over the 
joint, over the face, in the web space of the hand and for the scar contraction 
surgery. If the defect is large, better to go with split thickness graft. 
       Apart from secondary contraction, the full thickness graft has an advantage 
over the split thickness graft that it has the ability to grow, so full thickness graft is 
preferred especially in pediatric age group. 
      Epidermis during maturation phase may become 7-8 times thicker than the 
original by hyperplasia. This is clinically evident as crusting and scaling. This 
overgrowth of the epidermis will grow along the uncovered portion to aid the 
healing of the wound.  
     Hyperpigmentation in heavily pigmented individuals is poorly understood, 
especially when the graft is placed over palms and soles. This can be avoided by 
careful selection of the donor area or by avoiding sun exposure to prevent 
permanent hyperpigmentation. Also hyperpigmentation can be reduced by 
dermabrasion and the chemical peeling of the skin.  
     In the initial 30 days, the nerve fibres undergo degeneration within the graft 
after transplantation. By around 40 days, the newly formed nerve fibres will start 
invading the graft both from the periphery as well as from the graft base. Among 
these fibres most of them travel along the Schwann sheaths, that is left of the 
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original nerves or along the blood vessels. The fibrils multiply in number by 2-3 
months and reach the end organs near to the sweat glands, hair follicles and 
sensory end organs resulting in the crude reformation of the sensory network. 
      Grafted skin will be hypersensitive for a period of one year, which will be 
followed by touch, temperature and tactile discrimination. However neural 
architecture resembles that of the donor area. This sensation will be better and 
faster in full thickness graft than the split thickness graft.  
       The functioning of the sweat glands depends on the neural regeneration, hence 
sweat gland functioning is superior in the full thickness graft than the split 
thickness graft. It takes 2-3 months for the sweat glands to form sweat. Till then 
the grafted area will appear dry and scaly. This can be avoided by applying 
moisturizing cream. 
      Hair follicle growth is generally seen after full thickness graft and it maintains 
the property of the donor area. So for male pattern baldness and eye reconstruction, 
full thickness graft is preferred.  
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GRAFT FAILURE 
Causes of graft failure: 
1. Graft placed on an avascular bed  
2. Infection 
3. Hematoma 
4. Seroma 
5. Shearing 
6. Malnutrition 
7. Poor underlying medical condition 
8. Upside-down graft or other technical errors 
      Graft will fail when serum imbibitions or revascularization process is disturbed 
during the development period. The most important thing for the graft uptake is the 
healthy and vascularised bed. Inadequate bed is considered as one of the more 
common causes of the graft failure. Exposed tendons, cartilage and bone are 
considered as relative contraindications for the skin grafting, since they do not take 
up the graft well. 
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       Poorly vascularised tissues such as fat, peritoneum, perichondrium and 
periosteum support split thickness graft well when the granulation tissue is allowed 
to grow on them. 
       Blood, serum and pus when present between the graft and the host bed prevent 
the graft take. It can lead to complete or partial graft failure. This can be avoided to 
some extent by making vertical slits in the graft. 
      Another common cause of graft failure is shearing of the graft which occurs 
during the early post operative period while changing the dressing or mobilization 
of the extremity by the patient. To prevent it, dressing should be done carefully and 
the extremity should be immobilized. 
      Infection when present prevents the graft uptake, KRIEZK and ROBSON  
proved that if the bed contains greater than 10
5
 organism per gram of tissue, the 
survival of the graft can be hampered. Hence organism such as hemolytic 
streptococci and pseudomonas are considered as contraindications for the skin 
grafting. JAMES BARRETT BROWN and VILRAY PAPIN BLAIR suggested 
the freedom from systemic infection before the skin grafting to prevent failure. 
      Malnutrition, steroids, vasculitis, malignancy, chemotherapy and 
immunosuppression can result in unfavorable systemic or local conditions which 
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can have an effect on graft uptake. Previous radiation injury and pressure effect on 
the host or the donor site can also prevent total or partial graft take. 
      Dermatome and meshers too hot after sterilization, when used during the skin 
grafting can also affect the graft take.  
 
BLOOD COAGULATION: 
     Blood coagulation theories have existed since antiquity. Fibrin was explained 
by the physiologist, Johannes Müller as a substance of thrombus. Rudolf 
Virchow described its soluble precursor, Fibrinogen and Prosper Sylvain Denis  
chemically isolated it. 
    The process of the conversion from fibrinogen to fibrin is the result of 
an enzymatic process, and the labeled the hypothetical enzyme "thrombin" and its 
precursor "prothrombin” was suggested by Alexander Schmidt.  The essentiality 
of calcium in the coagulation of blood was discovered in1890, by Arthus. Giulio 
Bizzozero identified the platelets in 1865 and elucidated their functions in 1882. 
     Paul Morawitz, in 1905 consolidated the theory that presence of tissue factors 
is required for generation of thrombin. At this point it was known that the damaged 
tissue releases thrombokinase/thromboplastin(factor III) which reactes with 
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prothrombin along  with calcium to form thrombin and this converts fibrinogen to 
fibrin. 
      Thrombogenesis is the process where blood gets clotted. It is a process, where 
blood loss from a damaged vessel is controlled by formation of platelet and fibrin 
containing clot and subsequently the damaged vessel is repaired. 
      Thrombogenesis (Coagulation) is highly conserved throughout biology and it 
includes both a cellular (platelet) and a protein component (coagulation factors) 
and this hemostatic system in humans is very well understood and extensively 
researched.  
    Coagulation begins almost instantly when endothelium lining the blood vessel is 
injured. When the blood is exposed to tissue factors, it initiates changes in the 
platelets and fibrinogen, wherein the platelets immediately forms plug at the site of 
injury. This process is called as Primary hemostasis. 
     Proteins in the blood plasma, called the coagulation factors or clotting 
factors, respond in a complex cascade to form fibrin strands, which strengthen the 
platelet plug. This is called Secondary hemostasis    
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Physiology of coagulation: 
Formation of the platelet plug: 
Platelets play a major role in sealing of the smaller vessels by formation of the 
platelet plug. 
Physical and chemical characteristics of platelets: 
 Platelets are derived from megakaryocytes from the bone marrow. 
 Size ranges from 1-4micrometer in diameter. 
 The normal concentration of platelets in the circulation ranges between 
1,50,000-3,00,000/microlitres. 
 Half  life of platelets in the blood ranges from 8-12 days, which are 
removed by the tissue macrophages ( More than half in spleen). 
Functional characteristics: 
 Platelets donot have nuclei so they cannot reproduce, still they carry out 
arrays of functions and their cytoplasm contains: 
a) Contractile proteins such as actin and myosin which are similar to those in 
muscle cells and they also contain thrombosthenin which all together help in 
platelet contraction. 
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        Blood coagulation in vivo pathway showing central role of thrombin 
Note: TF: tissue factor                             TFPI: tissue factor pathway inhibitor 
          TXA2: thromboxane A2                 TM: thrombomodulin 
          ADP: adenosine diphosphate         ATIII: antothrombin III 
          PC: protein C                                 APC: activated protein C 
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b) Golgi apparatus and Endoplasmic reticulum residue store a large quantity of 
calcium ions and produce many enzymes. 
c) Mitochondria and enzyme system of the platelets have the capacity to produce 
adenosine triphosphate and diphosphate. 
d) Prostaglandins are generated by the enzyme systems which acts as local  
hormone on the vessels and perform other local reactions. 
e) Fibrin stabilizing factor. 
f) Contain growth factors which act on vascular endothelial cells, vascular smooth 
muscle cells and fibroblasts. 
      The cell membrane of platelets is coated with glycoprotein on their surface 
which aids in adherence of platelets to the injured endothelial cells and exposed 
collagen of the vessel wall. It also contains large quantities of phospholipids which 
initiate blood clotting process. 
Mechanism of platelet plug formation: 
     Once the platelets come in contact with injured vessel, particularly with the 
collagen, they change characteristics. It swells and attains irregular shape with 
numerous pseudopods irradiating and protruding from their surface.  
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     The contractile proteins present in the cytoplasm of platelet contract and release 
granules containing the active factors. The surface of platelets become sticky, 
which help in adhesion of platelet to the collagen of the vessel wall and von 
Willebrand factor (protein that leaks from the plasma into the tissue). Platelets 
release adenosine diphosphate and thromboxane A2, which once released activate 
other platelets and these additional platelets released become sticky and get 
adhered to the original activated platelet forming a platelet plug. Initially platelet 
will be loose and this is enough to seal a small vessel, but in larger vessels blood 
coagulation occur subsequently forming fibrin threads. These fibrin threads attach 
tightly to the platelet plug and form an unyielding plug.  
Cascade of coagulation: 
   The Secondary hemostasis of coagulation cascade has two paths which lead 
to the formation of fibrin and these are the intrinsic pathway (also known as 
contact activation pathway) and extrinsic pathway (also known as the the tissue 
factor pathway). Before it was thought that both the pathways has equal 
importance which joins the common pathway, but now it is known that tissue 
factor pathway is primarily required for the initiation of blood coagulation.  
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The coagulation cascade consists of three pathways. 
a) The Tissue factor pathway 
b)  The Contact activation pathway and  
c) Both activate the "final common pathway" of factor X, thrombin and fibrin. 
Tissue factor pathway or Extrinsic pathway: 
The main aim of this pathway is to generate a "thrombin burst”, it is a process 
wherein thrombin, the crux of the coagulation cascade in terms of its feedbacks, is 
rapidly released. Among all the activated factors, FVIIa is the one which circulates 
in highest amount. 
 It involves 
a) Release of tissue factor: tissue factor or tissue thromboplastin released when 
a vessel is traumatized functions as proteolytic enzymes. 
b) Activation of factor X: lipoprotein complex along with FVIIa activate FXa 
in the presence of calcium ions. 
c) Effect of FXa on prothrombin activator and role of FV: Following activation 
of FX, it immediately combines with tissue phospholipids along with FV to 
form prothrombin activator. This prothrombin activator in the presence of 
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calcium ions, splits prothrombin to thrombin and the coagulation process 
continues.  
d) Initially factor V will be in inactive form, the proteolytic activity of 
thrombin activates factor V and this activated factor V accelerates the 
prothrombin activation. Thus FVa acts as a protease in the activation of 
prothrombin activator complex, causing splitting of prothrombin to 
thrombin. It also accelerates the protease activity of FX and phospholipids 
which acts as a vehicle in the pathway. 
  
 
                     COAGULATION CASCADE                           
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Intrinsic pathway: 
a) Activation of factor XII and release of platelet phospholipids: Clotting 
factors such as FXII and platelets alter their configuration following trauma 
to the blood or on exposure of collagen. This alteration in molecular 
configuration of FXII converts itself into a proteolytic enzyme called 
“Activated factor XII”. Damaged platelet release platelet factor 3 which 
subsequently plays a role in clotting cascade. 
b) This activated FXIIa converts FXI to activated FXIa and the conversion 
requires high molecular weight kininogen (HMWK) and prekallikrein. 
c) This activated FXIa in turn activates factor IX. 
d) Activation of factor X and role of factor VIII: FIXa acts in concert with 
FVIII and platelet factor 3 and phospholipid activates factor X. So if factor 
VIII and platelets are deficient, the coagulation will not be complete. 
Final common pathway 
     Thrombin carries a large array of functions. The main function of thrombin is to 
convert fibrinogen to fibrin, which is the main foundation of a hemostatic plug. 
Thrombin in the presence of thrombomodulin also activates Factors VIII and V 
and their inhibitor protein C. The Factor XIII which is activated forms covalent 
bonds, that cross link the fibrin polymers that form from the activated monomers. 
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Until it is down-regulated by the anti-coagulant pathways, prothrombotic state of 
the coagulation cascade will be maintained by the continued activation of FVIII 
and FIX to form the tenase complex. 
Role of calcium: 
        Calcium plays a very important role in both intrinsic and extrinsic pathways. 
Calcium is required throughout the cascade except for the first two steps of 
intrinsic pathway. This indicates that calcium is required to accelerate the 
coagulation and in the absence of calcium, either of the pathways will not proceed. 
        So when blood is drawn for storage in the blood bank and for further 
transfusion purpose, clotting is prevented by reducing the threshold of calcium ions 
concentration by deionizing it with citrate ion or it is precipitated with oxalate ion. 
FIBRINOLYSIS: 
        Plasminogen is a plasma protein which when activated gets converted to 
plasmin. Plasmin is proteolytic enzyme and resembles pancreatic enzyme trypsin. 
This causes digestion of fibrin fibers and other procoagulants like factor V, factor 
VIII, factor XII and prothrombin and thereby digesting the clot. 
       For plasmin to lyse the clot, plasminogen has to be activated. Inactive form of 
plasminogen will be present in the clot. Once the bleeding is stopped, a few days 
49 
 
later the injured tissue and vascular endothelium will release a powerful factor 
called tissue plasminogen activator which in turn activates plasminogen resulting 
in formation of plasmin which ultimately clears off the clot. 
Blood clotting tests: 
a)Bleeding time: 
   Normal: 1 to 6 minutes 
  It is prolonged especially in the lack of platelets. 
 It is prolonged in the lack of several clotting factors also. 
b)Clotting time: 
  Normal: 6 to 10 minutes 
  Increased in deficiency of clotting factors 
c)Prothrombin time and INR: 
 Prothrombin time indicates the prothrombin in the blood  
 Normal : 12 seconds 
 INR is devised as a way to standardize measurements of Prothrombin time. 
International sensitivity index (ISI) is a assigned to each batch of tissue 
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factors, which indicates the activity of tissue factors with a standardized 
sample.  
  INR=(PT patient/PT normal)ISI 
 INR normal= 0.9 to 1.3 
 High INR of 4 or 5 indicates bleeding 
 Low INR of 0.5 indicates clot 
 Patients on warfarin, INR should be maintained between 2 and 3. 
 
                      
 
 
 
 
                               
 
                       Blood plasma after the addition of tissue factors  
                     forms a gel like structure- test for prothrombin time. 
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CRYOPRECIPITATE: 
 It is obtained by thawing the fresh frozen plasma and centrifuging 
it and the precipitate obtained is cryoprecipitate. 
 It is rich in fibrinogen and hence it is primarily used as a source of 
fibrinogen. 
Composition: 
Each unit of cryoprecipitate contains 
a) Factor VIII       : 80-120U/ concentrate 
b) Fibrinogen       : 150-250 mg/concentrate 
c) Factor XIII       : 20-30% of original FFP           
d) vWF   : 40-70% of original FFP 
Uses: 
a) Hemophilia A: since it contains factor VIII, it can be used in hemophilia A,  
currently Desmopressin acetate (DDAVP) or factor VIII or both is used for mild to 
moderate disease. 
b) It can be used in von Willebrand’s disorder. 
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c) Since it is rich in fibrinogen, it can be used for treating hypofibrinogenemia. 
d) Cryoprecipitate has been used as sealant along with thrombin due to abundance 
of fibrinogen. 
e) It is used in disseminated intravascular coagulation. 
f) It can aid massive hemorrahage. 
FRESH FROZEN PLASMA: 
     Fresh frozen plasma is obtained when citrated plasma is separated from whole 
blood and freezed within 8 hours of collection or citrated apheretic plasma is 
freezed within 6 hours. 
Storage: 
 when temperature is maintained at -180c or below, it can stored and used  
over a year. 
 There will be minimal loss of label coagulation factors like factor V and 
factor VIII under these circumstances. 
 Once fresh frozen plasma is thawed, it can be stored in the refrigerator for 
24 hours before it can be used. 
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FFP contains: 
a) All the coagulation factors 
b)  Plasma proteins 
c) Glucose -535mg/dl, Na+-12mEq/L, Cl-  73mEq/L, K+-3.5mEq/L, 
                     HCO3—15mEq/l 
 It is hyperosmolal, hyperglycemic, hypernatremic and hypochloremic. 
 FFP contains the stable as well as labile components of 
the coagulation, complement and fibrinolytic systems. Moreover it contain 
proteins that maintain the oncotic pressure, that modulate the immunity and 
other proteins that have diverse activities. In 
addition, fats, carbohydrates and minerals are present in similar 
concentrations to those present in circulation. 
Dose:  10-15ml/kg 
Plasma frozen within 24 hours (FP24): 
 The plasma which is frozen within 24 hrs has replaced the fresh frozen 
plasma largely. 
 FP24 contents are similar to those of fresh frozen plasma, except for factor 
VIII which is almost about 80% less in FP24 when compared to the FFP. 
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Uses: 
1. It is used in emergency situations where a patient is bleeding or in patients 
who are deficient in multiple coagulation factors undergoing an invasive 
procedure. 
2. It can be used in single factor deficiency where specific factor is not 
available. 
3. For reversal of warfarin therapy. 
4. It is used in thrombotic thrombocytopenic purpura (TTP). 
5. Disseminated intravascular coagulation and HELLP syndrome. 
6. Liver diseases and vitamin K deficiencies. 
7. Massive transfusion. 
Demerits: 
a) There is high chance of viral infectivity during transfusion including HIV 
infection. 
b) Chance of allergic or anaphylactic reactions. 
c) FFP should be ABO compatable, Rh typing can be disregarded to prevent 
agglutination reactions. 
d) FFP are not concentrates, so when transfused in large quantities can result in 
volume overload and cardiac failure. 
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SUTURES: 
Definition: 
 Surgical suture is a medical device used to hold body tissues together after an 
injury or surgery. OR  
 Suture is a piece of thread-like materials that is used to stitch or approximate 
tissues or hold the wound together until healing takes place. OR 
  Any strand of material used to ligate bleeders or used to approximate tissues. 
         It is applied generally by using a needle with an attached length of thread. It 
comes in a number of different shapes, sizes and thread materials that have been 
developed over in millennia. 
Classification of Suture Material: 
 Absorbable Suture: An absorbable suture is one that can be digested by 
body cells and fluids. 
 Absorption rate depends on various factors like the type of body tissue, 
nutritional status of the patient and the presence of infection. 
 Depending on the diameter and length, absorbable suture is available in 
prepackaged and presterilized forms in various sizes. Sizes range from 
number 5, which is the heaviest to number 12-0, which is the finest. The 
length ranges from 12 to 60 inches. 
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a) Plain gut-suture material produced from the sheep gut that has not been 
treated to lengthen its absorption time in the tissues.  
b) Chromic gut-plain catgut when treated with chromic oxide, so that it will 
delay its absorption or digestion. 
c) Synthetic absorbable sutures. 
1) Polyglactin (vicryl) 
2) Polyglycolic acid (dexon) 
3) Polydioxanone (PDS) 
 
2. Nonabsorbable Suture: The suture material which is not absorbed during 
the healing process. It becomes encapsulated with tissue and remains in the body 
until it is removed or cast off. 
 Non absorbable sutures Eg: Silk, nylon, cotton, linen, polypropylene and  
 corrosion-resisting steel wire. 
STAPLES: 
Surgical staples are specialized devices that are used in surgery in place of sutures 
 to close skin wounds, anastomose or to remove parts of the bowels or lung. 
Stapling is much faster than suturing that is done by hand, and also more accurate 
and consistent.  
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The technique was pioneered by a Hungarian surgeon, Humor Hultl, who is 
considered as the "father of surgical stapling". Hultl's prototype stapler was 
founded in 1908, which weighed eight pounds (3.6 kg) and was primarily devised 
to achieve leak proof anastomoses. 
Staples are classified depending on their material or shape. Most commonly 
medical staples are made from titanium or stainless steel, but they can also be 
made from other materials like iron, chromium, nickel or plastic. 
 Medical staples may be straight, curved or circular. 
TISSUE ADHESIVES: 
A) Fibrin glue, also called fibrin sealant, is a formulation which is made up 
of fibrinogen (lyophilised pooled human concentrate) and thrombin (bovine, which 
is reconstituted with calcium chloride) that is used to create fibrin clot, which can 
be applied to the tissue sites to glue them together. Thrombin is an enzyme which 
takes part in the coagulation cascade and converts fibrinogen into fibrin monomers 
between 10 and 60 seconds giving rise to a three dimensional gel. 
Factors that influence fibrin gel dimensions, giving rise to fine or coarse gel are: 
1. Changing concentration of fibrinogen 
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2. Changing concentration of thrombin: increase in concentration increases 
ultimate tensile strength 
3. Changing concentration of calcium 
4. pH 
5. Temperature 
 It may also contain aprotinin, fibronectin and plasminogen.  
Uses of fibrin glue: 
a) Repairing dural tear. 
b) Bronchial fistulas. 
c) To attain hemostasis after spleen and liver trauma. 
d) It can also be employed in "no sutures" corneal transplantation. 
B) Cyanoacrylate: 
 It is the generic name given to the family of strong fast-acting adhesives. 
Cyanoacrylates include methyl 2-cyanoacrylate, ethyl-2-cyanoacrylate, 
n-butyl cyanoacrylate and 2-octyl cyanoacrylate 
 It is commonly called as "Super Glue" and "Krazy Glue”. 
 It is mainly used as tissue adhesive and as an alternative for approximating 
two cut edges of skin. 
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Materials and Methods  
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                                METHODOLOGY:  
30 patients admitted in general surgery department and plastic surgery department 
in Coimbatore medical college undergoing split skin grafting will be studied 
prospectively between 19.11.2012 to 18.11.2013. 
 INCLUSION CRITERIA: 
 Age of the patients- 18 years to 80 years 
 Diabetic ulcers 
 Hypertensive ulcers 
 Traumatic ulcers 
 Burns   
 Post surgical raw area or Iatrogenic 
EXCLUSION CRITERIA: 
 Pregnancy 
 Children < 18 years and adults > 80 years 
 Malignant ulcers/ malignancies 
 Irradiation 
 Peripheral vascular diseases  
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 Co-morbid factors like anemia, hypertension, diabetes mellitus, etc. will be 
corrected where possible. 
 Antibiotics to be started, as part of pre-operative treatment in all patients 
undergoing split skin grafting.  
 Per-operatively each patient is used as the case and control, where fibrin 
glue is applied on one half and sutures and /or staples are applied on the 
other half of the same ulcer. 
  Examinations of the graft for anchorage is considered and graded 
satisfactory or not.  
 Examination of the wound will be started from third post-operative day 
onwards and will include inspection for the graft uptake, soakage and 
infection. 
 14th day scores by both the two observers for all the parameters will be 
considered final.  
 Examination will be continued for a minimum of 2 weeks and the scoring 
will be done by assessing the following three parameter, namely  
(1) Graft take 
(2) Soakage 
(3) Infection  
62 
 
Anchorage : 
a) Satisfactory 
b) Not satisfactory 
Scale I: Graft take 
 
 
 
Scale II: Soakage 
 
 
Graft take Scores 
91-100% 4 
81-90% 3 
71-80% 2 
61-70% 1 
<60% or patchy 0 
Soakage Scores 
No soakage 3 
Partially soaked 2 
Totally soaked 1 
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Scale III: Infection 
Infection Scores 
Mild 3 
Moderate 2 
Frank pus 1 
 
Post op follow up: 
 Observer I(scores) Observer II(scores) 
Parameters 3
rd 
day 
7
th 
day 
14
th 
day 
3
rd
 
month 
3
rd 
day 
7
th  
day 
14
th 
day 
3
rd 
 month 
Graft uptake         
Soakage         
Infection         
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Results : 
 Observers will give scores for both fibrin and sutures and/ staples separately. 
 Average of the 14th day score given by both the observers for each parameter 
will be taken into account. 
          Fibrin Sutures and staples 
Parameters Observer I  observer II Observer I  Observer II 
  Graft uptake     
     Soakage     
     Infection      
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MATERIALS AND METHODS : 
The wound beds of all the 30 patients included in the study were prepared well 
before surgery. Once the granulation tissue is adequate and pus culture and 
sensitivity report showed, no growth or micro-organism load is less than10
5 
/gram 
of tissue is achieved, the cases were posted for surgery. 
Materials required: 
a) Fibrin glue 
b) Sutures and/staples                                    Fibrinogen 
    a)Fibrin glue: contains two component  
        Thrombin 
Fibrinogen:  
 cryoprecipitate was used, since it is a rich source of fibrinogen.  
 There are enough literatures and articles to show that cryoprecipitate is rich 
source of fibrinogen. 
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Thrombin: 
 It was prepared according to the method described by Armand J Quick. 
  This was obtained from fresh frozen plasma (FFP) of healthy donors 
screened negative for HIV and Hepatitis B.  
 100 ml of FFP was thawed to 2- 4 0C and was 10 times diluted with distilled 
water, making 1000 ml of solution. 
  10 ml of 1% acetic acid was added to this to bring the pH 5.3 and this 
resulted in the formation of precipitate. 
  It was kept for half an hour and then centrifuged at 3000 rpm for 5 minutes. 
  The precipitate was collected and in this, normal saline was added to make 
it 100 ml and then pH was brought up to approximately 7 by titrating with 
sodium carbonate.  
 This was put in a water bath (37 0C) and 1 ml of 0.1 M CaCl2 (Calcium 
Chloride) was added. 
  The clot which formed in 45-120 seconds was removed by wrapping it 
around a stirring glass rod. 
  The thrombin solution thus prepared was water clear and was constant in 
potency. 
  The strength of thrombin was standardized to 10 second of thrombin time 
with the help of full strength thrombin solution. This thrombin solution was 
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stored in deep freeze at less than -20
0
C to maintain the potency and could be 
used up to a month.   
 Once the components are prepared, they were stored in deep freezer and 
used when required. 
 Cold chain was maintained. On the day of surgery, the components were 
taken out from the deep freezer and thawed to room temperature. Before 
surgery the wound bed is prepared well. Adequate thickness of graft is 
harvested. One component is sprinkled over the bed and the other 
component on the graft and graft is applied. 
 Once the graft is applied, it is checked for the anchorage by pulling it gently 
with forceps or moving the graft with hands and noted whether anchorage is 
satisfactory or not. 
 Grafted limb is immobilized and paraffin gauze is applied to the donor site. 
Subsequently in the post-operative period, Graft is monitored for graft 
uptake, soakage and infection by the observers and results are tabulated. 
 
  
 
  
68 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Results 
 
69 
 
RESULTS 
A) SEX DISTRIBUTION: 
 Total number of patients: 30 
          SEX      NUMBER PERCENTAGE 
           Males                    20            66.66% 
          Females              10            33.33% 
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                   Pie chart showing sex distribution  
 B) AGE DISTRIBUTION:  
Patients aged between 31 and 80 years are included in the study 
AGE IN YRS MALE FEMALE 
31-40 1 2 
41-50 5 4 
51-60 8 2 
61-70 5 1 
71-80 1 1 
 
66.6% 
33.3% 
MALES
FEMALES
71 
 
 
 
      Diagram showing total number of patients in different age group 
                                 
                   = 31- 40 YEARS                                                                               = 61-70 YEARS 
                    
                    = 41-50 YEARS                                                                              = 71-80 YEARS 
                                                                              
                    = 51-60 YEARS                                                                                              
 Maximum number of patients in the study comes under 51 to 60 years. 
 Least number of patients are of 71to 80 years. 
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Line diagram showing male and female distribution among different 
age group  
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C) DISTRIBUTION ACCORDING TO DIAGNOSIS: 
 
Bar diagram showing distribution of male and female sex according 
to the diagnosis  
                  DIABETES MELLITUS                         MALES 
                   HYPERTENSION                                FEMALES 
                   TRAUMA 
                   BURNS  
                   IATROGENIC (POST SURGERY RAW AREA) 
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D) ANCHORAGE PERCENTAGE: 
 
                          Diagram showing anchorage 
 
                   SATISFACTORY ANCHORAGE 
 
                   UNSATISFACTORY ANCHORAGE 
 
 Anchorage is satisfactory in 83.33% of cases 
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E) GRAFT UPTAKE SCORING 
GRAFT TAKE SCORE 
91-100% 4 
81-90% 3 
71-80% 2 
61-70% 1 
<60% or patchy 0 
 
 
                     Line diagram showing graft uptake scores 
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F) SCORING FOR SOAKAGE  
SOAKAGE SCORE 
No soakage 3 
Partially soaked 2 
Totally soaked 1 
 
 
          Diagram showing soakage scores  
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                     = 2 
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G) INFECTION SCORING: 
INFECTION SCORE 
Mild 3 
Moderate 2 
Frank pus 1 
 
 
                              Diagram showing scores given to infection 
                  MILD 
                  MODERATE  
                  FRANK PUS 
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H) COMPARISON BETWEEN FIBRIN AND SUTURES AMONG 
DIABETES MELLITUS PATIENTS: 
 Total of average scores given by both the observers is taken for each 
parameter. 
  Since the scores of fibrin is on the higher side it is taken as 100% 
(percentile) and compared with the sutures and staples. 
Parameter Fibrin(total scores) Sutures N staples (total 
scores) 
Graft uptake 35 34.5 
Soakage 26 22.5 
Infection 27.5 23 
 
Parameter Fibrin Sutures N staples Results of fibrin group 
Graft uptake 100% 90% 10% better  uptake 
Soakage 100% 86.53% 13.46% less soakage 
Infection 100% 83.63% 16.36%  less 
infection 
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Diagram showing graft uptake, soakage and infection in fibrin 
and control group among diabetic patients: 
 
 Anchorage in all diabetic patients was satisfactory.  
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I) COMPARISON BETWEEN FIBRIN AND SUTURES AMONG 
HYPERTENSIVE PATIENTS: 
 Total of average scores given by both the observers is taken for each 
parameter. 
 Since the scores of fibrin is on the higher side it is taken as 100%(percentile) 
and compared with the sutures and staples. 
Parameter Fibrin(total scores) Sutures N staples(total 
scores) 
Graft uptake 26.5 25 
Soakage 19.5 18 
Infection 19.5 18 
 
Parameter Fibrin Sutures N 
staples 
Results of fibrin 
group 
Graft uptake 100% 94.33% 5.67% better 
uptake 
Soakage 100% 92.30% 7.7% less soakage 
Infection 100% 92.30% 7.7% less infection 
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Diagram showing graft uptake, soakage and infection in 
fibrin and control group among hypertensive patients 
 
 Out of 7 patients anchorage was satisfactory in 6 patients. 
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J) COMPARISON BETWEEN FIBRIN AND SUTURES AMONG  
TRAUMA PATIENTS: 
 Total of average scores given by both the observers is taken for each 
parameter. 
 Since scores of fibrin is on the higher side it is taken as 100%(percentile) 
and compared with the sutures and staples. 
Parameter Fibrin(total scores) Sutures N staples(total 
scores) 
Graft uptake 30.5 29.5 
Soakage 21.5 21 
Infection 23 21.5 
 
Parameter Fibrin Sutures N staples Results of fibrin 
group 
Graft uptake 100% 96.72% 3.28% better  uptake 
Soakage 100% 97.67% 2.33% less soakage 
Infection 100% 93.47% 6.53% less infection 
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Diagram showing graft uptake, soakage and infection in fibrin and 
control group among trauma patients: 
 
 Anchorage was satisfactory in all patients.  
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K) COMPARISON BETWEEN FIBRIN AND SUTURES AMONG 
BURNS PATIENTS: 
 Total of average scores given by both the observers is taken for each 
parameter. 
 Since scores of fibrin is on the higher side it is taken as 100%(percentile) 
and compared with the sutures and staples. 
Parameter Fibrin(total scores) Sutures N staples(total 
scores) 
Graft uptake 11.5 11 
Soakage 8 7 
Infection 8 8 
 
Parameter Fibrin Sutures N staples Results of fibrin 
group 
Graft uptake 100% 95.65% 4.35% better uptake 
Soakage 100% 87.5% 12.5% less soakage 
Infection 100% 100% No difference 
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Diagram showing graft uptake, soakage and infection in 
fibrin and control group among burns patients 
 
 Anchorage was not satisfactory in burns patients. 
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M) COMPARISON BETWEEN FIBRIN AND SUTURES AMONG 
POST SURGERY RAW AREA PATIENTS: 
 Total of average scores given by both the observers is taken for each 
parameter. 
 Since scores of fibrin is on the higher side it is taken as 100%(percentile) 
and compared with the sutures and staples. 
Parameter Fibrin(total scores) Sutures N staples(total 
scores) 
Graft uptake 3.5 3 
Soakage 3 3 
Infection 3 3 
 
Parameter Fibrin Sutures N staples Results of fibrin 
group 
Graft uptake 100% 85.7% 14.29% better 
uptake 
Soakage 100% 100% No difference 
Infection 100% 100% No difference 
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Diagram showing graft uptake, soakage and infection in 
fibrin and control group among post surgery raw area 
patient 
 
 Anchorage was satisfactory  
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                                           STATISTICS: 
Since we are comparing two samples in a same individual for one parameter, we 
are joining the measurements or pairing it, in a sensible way to get a result. So we 
have chosen PAIRED T TEST in our study. 
Paired t test formula: 
 
The top of the formula is the sum of the differences (i.e. the sum of d). The bottom of the 
formula reads as the square root of the following n times the sum of the differences squared 
minus the sum of the squared differences, all over 
 n-1. 
a) The sum of the squared differences: ∑d2 means take each difference in turn, square it, and 
add up all those squared numbers. 
b) The sum of the differences squared: (∑d)2means add up all the differences and square the 
result. 
c) Brackets around something in a formula mean (do this first), so (∑d)2means add up all the 
differences first, then square the result. 
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GRAFT UPTAKE 
 MEAN S.D NO. 
Fibrin 3.57 0.47 30 
Sutures and 
staples 
3.33 0.51 30 
 
                                                PAIRED T TEST 
 
T- test Degree of 
freedom 
Probability significance 
3.751 29 0.001 P<0.01 
        
         P<0.01 – Significant at 1% level.  
SOAKAGE 
 MEAN S.D NO. 
Fibrin 2.60 0.46 30 
Sutures and 
staples 
2.38 0.55 30 
90 
 
  
                                            PAIRED T TEST 
T- test Degree  of 
freedom 
Probability significance 
3.067 29 0.005 P<0.01 
 
        P<0.01 – Significant at 1% level.                                  
INFECTION 
 MEAN S.D NO. 
Fibrin 2.70 0.43 30 
Sutures and 
staples 
2.45 0.48 30 
                                                 PAIRED T TEST 
T- test Degree  of 
freedom 
Probability significance 
3.340 29 0.002 P<0.001 
 
        P<0.01 – Significant at 1% level.                                  
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                                           Pre operative picture 
 
 
                                        Intra operative picture  
Serous discharge                                                             No Serous discharge 
 
 
           STAPLED AREA             FIBRIN GLUE APPLIED AREA 
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                                                  DISCUSSION 
 Wound healing by primary intention is the most desirable one. This 
has been the challenge for surgeons to achieve these feet since ages. 
To overcome this sutures were developed, but the expectations and 
dream of developing an ideal suture was not completely fulfilled. So 
we started looking for alternatives, that’s when we created tissue 
adhesives. Today we have both biological (Fibrin glue) and synthetic 
(Cyanoacrylate). 
 In our study we have used fibrin glue as tissue adhesive for fixing 
split skin grafting. 
 The principle behind using fibrin glue as tissue adhesive is born from 
the concept that, the first phase of inflammation involves formation 
of thrombus through a series of events that takes place in coagulation 
cascade. 
  In our study we have used fibrin glue, that is of human origin and 
bypassing the problem of anaphylactic reaction, which is encountered 
when fibrin glue of bovine origin is used.  
 The process of using fibrin glue in our setting was easy and 
comfortable, only loose string is preparation of thrombin from fresh 
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frozen plasma. Once thrombin is prepared, it is stored under -20
0
c to 
maintain the potency and can be used over a month. This helped to 
overcome the difficult and cumbersome method of conventional 
suturing and pain associated with stapling. 
 Our study is based on 30 patients, which mainly comprises of  
Males-20 patients, which accounts to 66.66% and Females-10 
patients, which accounts to 33.33% and this male dominance is 
consistent with world population. 
 Most of the patients were in the age group of 51-60years which 
accounts for 33.3% and least among 71-80 years accounting for 
6.66%. Others 31-40years=10%, 41-50years=30% and 61-70years= 
20%. 
 Out of the 30 patients in our study, diabetes mellitus dominated the 
strength of patients accounting for 33%, out of which 26.4% were 
males and 6.6% were females, indicating the shift of diabetic 
epidemic towards India. 
 Strength of trauma in our study was 26.66% with males being 
19.99% and females-6.66%. 
 Hypertension association in our study was 23.33% with male 
population being 16.66% and females making up to 6.66%. 
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 Only 4 burns patients participated in the study, out of 75% were 
females and one male patient. With one post modified mastectomy 
raw area patient in the study. 
 Anchorage was satisfactory in 83.33% of the cases, except for burns 
patients and one patient with hypertension, where anchorage was not 
satisfactory.  Anchorage in our study was comparable to study done 
by Saxena et al 
[1]
, Varanasi, India in fixing split skin grafting/ flaps 
using fibrin glue. The results were consistent and satisfactory when 
compared to this study. Anchorage of the graft to bed was rapid, the 
time consumed for the procedure was very short when compared to 
conventional suturing and/ or stapling, these can be corroborated with 
those of Marcos et al 
[2]
. 
 Overall graft uptake was better in fibrin glue study group. Also 
soakage and infection was less in fibrin glue study group, when 
compared to the conventional suturing /stapling. 
 Among diabetic patients, graft uptake was 10% better, 13.46% less 
soakage and 16.36% less infectious when compared with the control 
group. 
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 In hypertensive patients, graft uptake was better by 5.67% and 
superiority among soakage and infection with 7.7% less soakage and 
7.7% less infection.  
 When post traumatic raw area group was considered, graft taken was 
3.28% better with 2.33% less soakage and 6.53% less infection. 
 Though the anchorage was not so satisfactory among the burns 
patients, graft uptake was 4.35% better, 12.5% less seroma formation 
when compared to control group. But no difference in infection was 
found among both the groups. 
 In post surgical raw area patient, no difference in soakage and 
infection was found, but the graft uptake was significantly better by 
14.29%. 
 Graft uptake in our study is similar to the study conducted by the 
Saxena et al 
[1]
. The findings in our study also corroborates with those 
of Machado et al
[3]
, where fibrin glue was used for skin grafting and 
second intention wound healing following dermatalogic surgeries like 
excision of malignant epithelial cutaneous tumors. 
 Soakage in our study among cases was very less when compared to 
the control group. These findings were comparable to Saxena et al 
[1]
 
study. There are more evidence, when fibrin glue was used as 
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a sealant in Abdominoplasty, seroma and soakage formation was less 
according to the study conducted by the Marcos et al 
[2]
. According to 
Dragan et al study 
[4]
, fibrin glue can be used as sealant to prevent 
pocket related complications in patients undergoing pacemaker 
tansplantations. This shows that fibrin glue is a very good sealant or a 
hemostatic agent, seroma formation following its application will be 
very minimal. There are enough literature and studies to show that it 
is very efficacious as a sealant. 
 Even though diabetic patients are prone for infections, infection rate 
among diabetic patients were less in fibrin glue study group following 
grafting. This can be corroborated to those of study conducted on rats 
by Jabs et al 
[5]
 , where they inoculated wound with staphylococcus 
and grafts was placed. The graft was still better among infected 
wounds. 
 In our study no difference in infections rate was found among burns 
and postsurgical raw area patients. In burns patient the bed was 
devascularised and in postsurgical raw area patient, the bed supplied 
enough nutrition for equal take of graft. 
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                                             CONCLUSION: 
 
 This is a Prospective comparative study. 
 Thirty patients were included in the study with male preponderance. 
 Patients aged between 31 and 80 years were included in the study, with 
highest influence of  patients between 51 and 60 years accounting for 33.3% 
and least among 71-80 years age group accounting for 6.66%. 
 Major strength of the study was covered by diabetics and trauma patients. 
  Anchorage was rapid and excellent in most of the patients except for burns 
patients were standards were not met. 
 Graft uptake, soakage and infection rate among all the patients in fibrin glue 
group was better and satisfactory compared to control group, expect no 
difference in infection rate among burns and post surgical raw area patients 
and no difference in soakage in post surgical raw area patient was found. 
 We have advocated paired T test in our study and results were significant, 
proving that the application of fibrin glue in fixing skin grafting when 
compared to conventional method of suturing and stapling is simple, 
efficacious, cost-effective, less time consuming, better graft uptake, less 
seroma formation, minimum infection, easy and comfortable intra-operative 
and post-operative care and patients can be made ambulant early. 
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 Hence we conclude that this can be considered as a very good alternative to 
conventional suturing and stapling. 
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Appendix -II 
PROFORMA 
Name:           DOA: 
Age/ Sex:                    DOS: 
Occupation:                    DOD: 
Address:  
CHIEF COMPLAINTS: 
1. Ulcer over extremities- onset and progress 
2. H/o burns 
3. H/O trauma 
PAST HISTORY 
1. H/O DM/ HTN/ Asthma/  TB/ Epilepsy 
2. H/O malignancy/irradiation. 
3. H/O chronic cardiac disease/chronic liver disease/ chronic renal 
disease/vasculitis 
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PERSONAL HISTORY: 
1. H/O of present conception 
2.  Smoker/ Alcoholic 
3.  Bowel and bladder habits, sleep pattern. 
 
GENERAL PHYSICAL EXAMINATION: 
1. Hydration 
2. Nutritional status 
3. Pallor  
4. Icterus  
5. Cyanosis/ clubbing/ edema 
6. Generalized/ regional lymphadenopathy 
7. Pulse rate 
8. Blood pressure. 
SYSTEMIC EXAMINATION: 
 Cardiovascular system: 
Inspection 
          Auscultation 
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 Respiratory system: 
Inspection  
          Percussion  
         Auscultation 
 Central nervous system: 
Consciousness 
          Orientation 
 Higher mental functions 
 Per abdomen:  
Inspection 
         Auscultation 
LOCAL EXAMINATION: 
Inspection: 
 Number, site, extent, shape and size 
 Margins- undermined/ punched out/ sloping/ rolled out or everted 
 Floor of the ulcer 
  Discharge 
 Adjacent area                     
107 
 
Palpation:  
 Temperature and tenderness 
 Margins- Induration and base 
 Mobility  
 Examination of regional lymph nodes 
 Examination for vascular diseases- peripheral pulses 
 Examination for nerve lesions  
Others: 
   Ankle brachial index 
    Body mass index 
Diagnosis: 
 
 
Investigations: 
1. Complete hemogram, random blood sugar, blood urea, serum 
creatinine and serum electrolytes. 
2. Liver function tests, serum proteins 
3. pus culture and sensitivity 
4. Electrocardiogram 
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5. Chest radiograph- PA view 
6. Test for HIV I & II, HBsAg 
7. And relevant investigations for associated medical conditions 
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CONSENT FORM 
 
    It has been explained to me in my mother tongue and I completely understand 
my condition, its related complications and the treatment options available. I 
have been explained in detail regarding this study- ‘TWO COMPONENT 
PREPARATION OF FIBRIN GLUE AND ITS CLINICAL EVALUATION IN 
SPLIT SKIN GRAFTING”. I hereby give my voluntary and willful consent to 
participate in the above mentioned study. 
DATE:                                                                              PLACE: 
 
 
  SIGNATURE OF THE                                               SIGNATURE OF THE 
          PATIENT                                                                     RELATIVE 
     (WITH NAME)                                                             (WITH NAME) 
 
                                            SIGNATURE OF THE 
                                                     WITNESS 
                                                 (WITH NAME) 
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                   MASTER CHART 
 
S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin 
 
S
L.
N
O 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
    SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY)  
     S 
 
NS 
 
1 
 
PALANISAMY 
 
64Y/M 
 
TRAUMATIC 
ULCER 
 
20X8 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECTI
ON 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S 
N 
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 2 3 2 2 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14 th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
 
2 
 
THANGAMANI 
 
48Y/F 
 
POST MRM 
RAW AREA 
 
10X 
10 
 
 
 3  rd 4 4 4 4 2 2 2 2 3 3 3 3       
7  th 4 3 3 3 3 3 3 3 3 3 3 3       
14 th 4 3 3 3 3 3 3 3 3 3 3 3 3.
5 
3 3 3 3 3 
3 SELVARAJ 54Y/M DIABETIC 
FOOT 
12X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 3 3 3 3 2 2 3 3 2 2       
14  th 4 4 3 3 3 3 2 2 3 3 2 2 4 3 3 2 3 2 
4 RANGASAMY 42Y/M HYPERTENSIVE 
ULCER 
6X4   
 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
5 MARIMUTHU 52Y/M TRAUMATIC 
ULCER 
12X8  
 
 3  rd 4 4 4 4 2 2 2 2 3 3 3 3       
7  th 3 4 3 3 2 2 2 2 3 3 2 2       
14  th 3 4 3 3 2 2 2 2 3 3 2 2 3.
5 
3 2 2 3 2 
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S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin 
 
SL.
NO 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
  SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY) 
 
     S 
 
NS 
 
6 
 
MURUGESAN 
 
46Y/M 
 
DIABETIC 
ULCER 
 
10X 
10 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECT
ION 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S
N
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 3 3 3 3 2 2 3 3 2 2       
14  th 4 4 3 3 3 3 2 2 3 3 2 2 4 3 3 2 3 2 
 
7 
 
VASANTHI 
 
51Y/F 
 
TRAUMATIC 
ULCER 
 
10X 
8 
 
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
8 KARUPPASAMY 44Y/M TRAUMATIC 
ULCER 
20X6   
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 4 3 2 2 2 2 3 2 3 2       
14  th 4 3 4 3 2 2 2 2 3 2 3 2 3.
5 
3.
5 
2 2 2.
5 
2.
5 
9 BALAMURUGAN 41Y/M BURNS 40X 
30 
  
 
3  rd 3 3 3 3 2 2 2 2 3 3 3 3       
7  th 2 2 2 2 2 2 1 1 2 2 2 2       
14 th 2 2 2 2 2 2 1 1 2 2 2 2 2 2 2 1 2 2 
10 DANIEL 59Y/M HYPERTENSIVE 
ULCER 
10X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 3 3 3 3 2 2 3 3 2 2       
14  th 4 4 3 3 3 3 2 2 3 3 2 2 4 3 3 2 3 2 
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S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin 
 
SL.
NO 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
   SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY)  
S 
 
NS 
 
11 
 
BALLAN 
 
61Y/M 
 
DIABETIC 
ULCER 
 
14X8 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECT
ION 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S
N
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 3 3 3 2 2 2 2 2 2 2 2       
14  th 3 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 
 
12 
 
KUPPATHAL 
 
63Y/F 
 
DIABETIC 
ULCER 
 
10X 
8 
 
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 3 3 3 2 2 2 3 3 2 2       
14  th 4 3 3 3 3 2 2 2 3 3 2 2 3.
5 
3 2.
5 
2 3 2 
13 KANNAN 70Y/M DIABETIC 
ULCER 
8X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 4 3 3 2 2 2 2 3 3 2 2       
14  th 3 4 3 3 2 2 2 2 3 3 2 2 3.
5 
3 2 2 3 2 
14 ABU BAKKAR 51Y/M DIABETIC 
ULCER 
14X8  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 4 3 2 2 2 2 3 3 3 3       
14  th 4 3 4 3 3 3 3 3 3 3 3 3 3.
5 
3.
5 
3 3 3 3 
15 SIVAKUMAR 57Y/M HYPERTENSIVE
ULCER 
10X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
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S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin. 
 
SL.
NO 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
    SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY)  
     S 
 
NS 
 
16 
 
KAMATCHI 
CHETTIYAR 
 
78Y/M 
 
DIABETIC 
ULCER 
 
12X4 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECT
ION 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S
N
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 3 3 3 3 2 2 3 3 3 2       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 3.
5 
3 3 2 3 2.
5 
 
17 
 
ANWAR 
 
32Y/M 
 
TRAUMATIC  
ULCER 
 
20X 
12 
 
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
18 RAJENDRA 48Y/M DIABETIC 
ULCER 
10X8  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 4 3 4 3 2 3 2 3 2 3 2       
14  th 3 4 3 4 3 2 3 2 3 2 3 2 3.
5 
3.
5 
2.
5 
2.
5 
2.
5 
2.
5 
19 BANNARI 42Y/F BURNS 20X 
15 
  
 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 3 3 3 2 2 2 2 2 2 2 2       
14  th 3 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 
20 VELUSAMY 60Y/M HYPERTENSIVE 
ULCER 
8X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
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S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin 
SL.
NO 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
   SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY)  
     S 
 
NS 
 
21 
 
TAMILSELVAN 
 
54Y/M 
 
TRAUMATIC 
ULCER 
 
22X 
14 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECT
ION 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S
N
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 3 3 2 3 2 2 2 3 2 2       
14 th 4 3 3 3 2 3 2 2 2 3 2 2 3.
5 
3 2.
5 
2 2.
5 
2 
 
22 
 
ANITHA 
 
33Y/F 
 
BURNS 
 
20X 
18 
  
 
3  rd 3 3 3 3 3 3 3 3 3 3 3 3       
7  th 3 3 3 3 2 2 2 2 2 2 2 2       
14  th 3 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 
23 PERIASAMY 66Y/M TRAUMATIC 
ULCER 
15X7  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
24 SUMITHA 48Y/F BURNS 24X 
16 
  
 
3  rd 4 3 4 3 2 2 2 2 3 2 2 2       
7  th 4 3 3 3 2 2 2 2 2 2 2 2       
14  th 4 3 3 3 2 2 2 2 2 2 2 2 3.
5 
3 2 2 2 2 
25 NATCHI 
MUTHU 
67Y/M DIABETIC 
ULCER 
11X5  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 4 4 3 3 3 3 3 3 3 3 3       
14  th 3 4 4 3 3 3 3 3 3 3 3 3 3.
5 
3.
5 
3 3 3 3 
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S= satisfactory; NS= not satisfactory; S and S= sutures and staples; FB= fibrin 
 
SL.
NO 
     NAME  AGE/ 
SEX 
DIAGNOSIS SIZE ANCHORAGE OBSERVATION 
DAY 
  GRAFT                   
UPTAKE 
   SOAKAGE    INFECTION 
 
RESULTS 
(14 TH DAY)  
     S 
 
NS 
 
26 
 
LAKSMI 
 
72Y/F 
 
HYPERTENSIVE 
ULCER 
 
10X5 
 
 
 
 
 
  
 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
 
FIBRIN 
 
S&S 
GRAFT
UPTAKE 
SOAKA
GE 
INFECT
ION 
     
F 
B      
 
S
N
S 
 
F
B 
  
F
B 
 
S
N
S 
I II I II I II I II I II I II S
N
S 
3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 3 3 3 2 2 2 2 2 2 2 2       
14  th 3 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 
 
27 
 
RATHINAM 
 
51Y/M 
 
HYPERTENSIVE 
ULCER 
 
9X 
4 
 
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
28 KALPANA 38Y/F DIABETIC 
ULCER 
13X9  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 3 3 3 3 2 2 2 2 2 2 2 2       
14  th 3 3 3 3 2 2 2 2 2 2 2 2 3 3 2 2 2 2 
29 CHRISTINA 51Y/F HYPERTENSIVE 
ULCER 
8X4  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 3 3 3 3 2 2 2 3 2 2 2       
14  th 4 3 3 3 3 2 2 2 3 2 2 2 3.
5 
3 2.
5 
2 2.
5 
2 
30 NIRMALAMM
A 
41Y/F TRAUMATIC 
ULCER 
8X6  
 
 3  rd 4 4 4 4 3 3 3 3 3 3 3 3       
7  th 4 4 4 4 3 3 3 3 3 3 3 3       
14  th 4 4 4 4 3 3 3 3 3 3 3 3 4 4 3 3 3 3 
